(2S,3R)-1-Benzhydryl-2-methylazetidin-3-yl ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate

Catalog No. :
ACZFIV205
CAS No. :
165034-60-6
Molecular Formula :
C27H33NO4S
Molecular Weight :
467.63

IUPAC Name:(2S,3R)-1-benzhydryl-2-methylazetidin-3-yl ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate

(2S,3R)-1-Benzhydryl-2-methylazetidin-3-yl ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$293.00Login to see priceInquiryInquiry
1g98%$587.00Login to see priceInquiryInquiry
5g98%$1763.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3R)-1-Benzhydryl-2-methylazetidin-3-yl ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate
IUPAC Name(2S,3R)-1-benzhydryl-2-methylazetidin-3-yl ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate
Molecular FormulaC27H33NO4S
Molecular Weight467.63
SMILESC[C@@H]1N(C(C2=CC=CC=C2)C3=CC=CC=C3)C[C@H]1OS(C[C@]4(C5(C)C)C(C[C@]5([H])CC4)=O)(=O)=O
InChI KeyXUYPDQBSUOZFAA-JVGMMHMTSA-N
Synonym(2S,3R)-1-benzhydryl-2-methylazetidin-3-ol ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate
CAS No.165034-60-6

Synthetic Route by SureRoute

1. ACZFIV205 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYHUS972 route compound structure diagram
    ACYHUS97239262-22-1 In Stock
  2. Plus
  3. ACEXWV452 route compound structure diagram
    ACEXWV452164906-64-3 In Stock
  4. Then
  5. ACZFIV205 route product structure diagram
    ACZFIV205165034-60-6
Inquiry

2. ACZFIV205 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZFIV205 route product structure diagram
    ACZFIV205165034-60-6
Inquiry

Comments (0)